Infectious Diseases News and Research

RSS

Experimental vaccine completely protects cynomolgus macaques against lethal Sudan virus

A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.

3 Feb 2023

The human body develops strategies to prevent the immune response from overshooting its mark

The signaling molecules of the immune system should trigger a response only where necessary. To prevent a life-threatening spread to the rest of the body, connective tissue can absorb these molecules like a sponge.

3 Feb 2023

Researchers explore mass gatherings and COVID-19 transmission

A recent study examines how mass gatherings in Hong Kong were associated with the local transmission of SARS-CoV-2.

3 Feb 2023

New electrochemical sensing technology enables detection of SARS-CoV-2 antigen-specific antibodies

Not all SARS-CoV-2 infections are created equal. We have learned this through multiple virus waves are taking their toll on the world's population.

3 Feb 2023

Oncodesign Services looks to the future

As Oncodesign evolves into Oncodesign Services and begins its journey as an independent business, CEO Fabrice Viviani explains his hopes and plans for the company’s future.

From Oncodesign Services 3 Feb 2023

Experts outline NIH's COVID-19 research response

Leaders from the National Institutes of Health and partner organizations outline NIH's COVID-19 research response in a policy forum in the journal Science.

2 Feb 2023

Pfizer COVID-19 vaccine protects against reinfection in long-term care facility staff

Researchers examines the effectiveness of the Pfizer-BioNTech COVID-19 vaccine among long-term care facility staff members.

2 Feb 2023

BCG vaccine does not protect elderly with co-morbidities against COVID-19

The tuberculosis vaccine (or BCG vaccine) does not protect elderly with co-morbidities against disease symptoms caused by a coronavirus infection.

2 Feb 2023

Immunocompromised patients more likely to die if hospitalized with COVID-19, study confirms

People with weakened immune systems remain more likely to die if hospitalized with COVID-19 than patients with normal immune systems, a new UK study has confirmed.

1 Feb 2023

Researchers utilize discarded facial tissues to diagnose respiratory viral infections in children

Researchers developed an innovative method to diagnose respiratory viral infections (RVIs) in children using discarded facial tissues.

1 Feb 2023

Risk factors for Omicron reinfections among previously infected frontline workers in the United States

Researchers examined a prospective cohort of frontline workers in the United States (US) previously infected with SARS-CoV-2. They attempted to identify risk factors that made this highly vulnerable population prone to reinfection by SARS-CoV-2 new variant of concern (VOC), Omicron, known for its high immune evading potential.

1 Feb 2023

Analysis of rebound virus suggests two separate reservoirs of latent HIV in patients

When people living with HIV take antiviral therapy (ART), their viral loads are driven so low that a standard blood test cannot detect the virus.

1 Feb 2023

Researchers develop new way to increase the potency of cancer vaccines

A new way to significantly increase the potency of almost any vaccine has been developed by researchers from the International Institute for Nanotechnology (IIN) at Northwestern University.

31 Jan 2023

Study demonstrates intrahost MPXV variation within a single lesion

Researchers reported on the clinical and molecular characteristics of MPXV infections in Finland.

31 Jan 2023

Study: COVID-19 is a significant cause of death in children and young people in the U.S.

COVID-19 was the underlying cause of death for more than 940,000 people in the US, including over 1,300 deaths among children and young people aged 0–19 years.

30 Jan 2023

Structure and function of the first FDA-approved treatment for Ebola virus discovered

Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus).

30 Jan 2023

Experimental vaccine against Marburg virus shows promise in first-in-human clinical trial

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

30 Jan 2023

New model shows how infectious diseases evolve in space and time

A new disease model that can account for contact patterns between age groups shows how infectious diseases evolve in space and time and how to predict future case numbers across a region.

30 Jan 2023

NCI awards $3.5 million grant to eliminate cervical cancer among women with HIV in low-resource countries

Weill Cornell Medicine, Moffitt Cancer Center in Tampa, Fla., and the University of North Carolina have received a $3.5 million, five-year grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to improve screening and preventative treatment of cervical cancer for women living with HIV in low-resource countries.

30 Jan 2023

Study evaluates post-acute sequelae of COVID-19 in US university

Researchers examined the prevalence and predictors of long coronavirus disease (COVID) in a sample representing a Washington, DC University staff in the United States of America (USA).

30 Jan 2023

Infectious Diseases News and Research

Experimental vaccine completely protects cynomolgus macaques against lethal Sudan virus

The human body develops strategies to prevent the immune response from overshooting its mark

Researchers explore mass gatherings and COVID-19 transmission

New electrochemical sensing technology enables detection of SARS-CoV-2 antigen-specific antibodies

Oncodesign Services looks to the future

Experts outline NIH's COVID-19 research response

Pfizer COVID-19 vaccine protects against reinfection in long-term care facility staff

BCG vaccine does not protect elderly with co-morbidities against COVID-19

Immunocompromised patients more likely to die if hospitalized with COVID-19, study confirms

Researchers utilize discarded facial tissues to diagnose respiratory viral infections in children

Risk factors for Omicron reinfections among previously infected frontline workers in the United States

Analysis of rebound virus suggests two separate reservoirs of latent HIV in patients

Researchers develop new way to increase the potency of cancer vaccines

Study demonstrates intrahost MPXV variation within a single lesion

Study: COVID-19 is a significant cause of death in children and young people in the U.S.

Structure and function of the first FDA-approved treatment for Ebola virus discovered

Experimental vaccine against Marburg virus shows promise in first-in-human clinical trial

New model shows how infectious diseases evolve in space and time

NCI awards $3.5 million grant to eliminate cervical cancer among women with HIV in low-resource countries

Study evaluates post-acute sequelae of COVID-19 in US university

Industry Focus: Infectious Diseases eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News